Biocon Biologics is all set to go public in the next two years. The company, a subsidiary of Biocon, has a pipleline of new biosimilar launches lined up for this year which it believes will power its business this year. BTTV Sakshi Batra was in conversation with Shreehas Tambe, CEO & MD of the company.